The use of dermal substitutes in burn surgery: Acute phase

Wound Repair and Regeneration

Volumn 22, Issue 1, 2014, Pages 14-22

  Shahrokhi, Shahriar ^a   Arno, Anna ^a,b   Jeschke, Marc G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BIOPOLYMER; COLLAGEN; COLLAGEN SPONGE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; MACROGOL; POLYBUTYLENE TEREPHTHALATE; POLYESTER; POLYGLACTIN; SILICONE;

ARTIFICIAL SKIN; BIOCOMPATIBILITY; BURN; BURN SCAR; CHRONIC WOUND; DERMAL SUBSTITUTE; ESTHETICS; FUNCTIONAL ASSESSMENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REGENERATIVE MEDICINE; REVIEW; RISK BENEFIT ANALYSIS; SPLIT THICKNESS SKIN GRAFT; STEM CELL; TECHNOLOGY; TISSUE ENGINEERING; WOUND CARE; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

BURNS; CELL CULTURE TECHNIQUES; CICATRIX; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 84891762729     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12119     Document Type: Review

References (60)

1. Lee KH,. Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J 2000; 41: 774-779.
2. Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G,. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 2007; 33: 946-957.
3. Van Der Veen VC, van der Wal MBA, van Leuwen MCE, Ulrich MMW, Middelkoop E,. Biological background of dermal substitutes. Burns 2010; 36: 305-321.
4. Hodgkinson T, Bayat A,. Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design. Arch Dermatol Res 2011; 303: 301-315.
5. Saffle JR,. Predicting outcomes of burns. N Engl J Med 1998; 338: 387-388.
6. Richters CD, Pirayesh A, Hoeksema H, Kamperdijk WA, Kries RW, Dutrieux RP, et al. Development of a dermal matrix from glycerol preserved allogeneic skin. Cell Tissue Banking 2008; 9: 309-315.
7. Machens HG, Berger AC, Mailaender P,. Bioartificial skin. Cells Tissues Organs 2000; 167: 88-94.
8. Zuijlen van PP, Angeles AP, Kreis RW, Bos KE, Middelkoop E,. Scar assessment tools: implications for current research. Plast Reconstr Surg 2002; 109: 1108-1122.
9. Bombaro KM, Engrav LH, Carrougher GJ, Wiechman SA, Faucher L, Costa BA, et al. What is the prevalence of hypertrophic scarring following burns? Burns 2003; 29: 299-302.
10. Akguner M, Barutcu A, Yilmaz M, Baratas O, Vayvada H,. Marjolin's ulcer and chronic burn scarring. J Wound Care 1998; 7: 121-122.
11. Leventhal D, Furr M, Reiter D,. Treatment of keloids and hypertrophic scars. Arch Facial Plast Surg 2006; 8: 362-368.
12. der Veen van VC, Boekema BKHL, Ulrich MMW, Middelkoop E,. New dermal substitutes. Wound Repair Regen 2011; 19: S59-S65.
13. Boyce ST,. Cultured skin substitutes: a review. Tissue Eng 1996; 2: 255-269.
14. Alisky JM,. Xenografts are an achievable breakthrough. Med Hypotheses 2004; 63: 92-97.
15. Burke JF, Yannas IV, Quinby JWC, Bondoc CC, Jung WK,. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-428.
16. Wang H, Pieper J, Peters F, van Vlitterswijk CA, Lamme EN,. Synthetic scaffold morphology controls human dermal connective tissue formation. J Biomed Mater Res 2005; 74: 523-532.
17. Arno A, Smith AH, Blit PH, Al Shehab M, Gauglitz GG, Jeschke MG,. Stem cell therapy: a new treatment for burns? Pharmaceuticals 2011; 4: 1355-1380. doi: 10.3390/ph4101355.
18. Leclerc T, Thepenier PJ, Bey E, Peltzer J, Trouillas M, Duhamel P, et al. Cell therapy of burns. Cell Prolif 2011; 44: 48-54.
19. Prunieras M, Regnier M, Woodley D,. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol 1983; 81 (1 Suppl.): 28s-33s.
20. Andreadis ST, Hamoen KE, Yarmush ML, Morgan JR,. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J 2001; 15: 898-906.
21. Ghosh MM, Boyce S, Layton C, Freedlander E, Mac Neil S,. A comparison of methodologies for the preparation of human epidermal-dermal composites. Ann Plast Surg 1997; 39: 390-404.
22. Ralston DR, Layton C, Dalley AJ, Boyce SG, Freedlander E, Mac Neil S,. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br J Dermatol 1999; 140: 605-615.
23. Jones I, Currie L, Martin R,. A guide to biological skin substitutes. Br J Plast Surg 2002; 55: 185-193.
24. Wainwright DJ,. Use of an acellular allograft dermal matrix (AlloDerm) in the management of fullthickness burns. Burns 1995; 21: 243-248.
25. Bello YM, Falabella AF, Eaglstein WH,. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001; 2: 305-313.
26. Pirayesh A, Monstrey S, Blondeel P, Hoekstra H, Vanoorbeek J, Hoeksema, H, et al. Development of a novel dermal substitute based on glycerinized allograft: clinical (Phase I) and experimental evaluation. Burns 2007; 33: S13.
27. Rennekampff HO,. Hautersatzverfahren in der Verbrennungschirurgie. Unfallchirurg 2009; 112: 543-549.
28. Ge L, Zheng S, Wei H,. Comparison of histological structure and biocompatibility between human acellular dermal matrix (ADM) and porcine ADM. Burns 2009; 35: 46-50.
29. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH,. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980; 14: 107-132.
30. Dantzer E, Queruel P, Salinier L, Palmier B, Quinot JF,. Dermal regeneration template for deep hand burns: clinical utility for both early grafting and reconstructive surgery. Br J Plast Surg 2003; 56: 764-774.
31. Gottlieb ME, Furman J,. Successful management and surgical closure of chronic and pathological wounds using integra. J Burns Surg Wound Care 2004; 3: 4-60.
32. Muangman P, Engrav LH, Heimbach DM, Harunari N, Honari S, Gibran NS, et al. Complex wound management utilizing an artificial dermal matrix. Ann Plast Surg 2006; 57: 199-202.
33. Murray RC, Gordin EA, Saigal K, Leveenthal D, Krein H, Heffelfinger RN,. Reconstruction of the radial forearm free flap donor site using integra artificial dermis. Microsurgery 2011; 31: 104-108.
34. Chalmers RL, Smock E, Geh JLC,. Experience of integra in cancer reconstructive surgery. JPRAS 2010; 63: 2081-2090.
35. Shores JT, Gabriel A, Gupta S,. Skin substitutes and alternatives: a review. Adv Skin Wound Care 2007; 20: 493-508.
36. Clark RAF, Ghosh K, Tonnesen MG,. Tissue engineering for cutaneous wounds. J Invest Dermatol 2007; 127: 1018-1029.
37. Nguyen DQA, Potokar TS, Price P,. An objective long-term evaluation of integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns 2010; 36: 23-28.
38. Ruszczak Z,. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 2003; 55: 1595-1611.
39. Sheridan RL, Hegarty M, Tompkins RG, Burke JF,. Artificial skin in massive burns: results to ten years. Eur J Plast Surg 1994; 17: 91-93.
40. Yannas IV, Burke JF,. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980; 1: 65-81.
41. Nanchatal J, Dover R, Otto WR,. Allogeneic skin substitutes applied to burns patients. Burns 2002; 28: 254-257.
42. Branski LK, Herndon DN, Pereira C, Mlcak RP, Celis MM, Lee JO, et al. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 2007; 35: 2615-2623.
43. Fette A,. Integra artificial skin in use for full-thickness burn surgery: benefits or harms on patient outcome. Technol Health Care 2005; 13: 463-468.
44. Haslik W, Kamolz LP, Manna F, Hladik M, Rath T, Frey M,. Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm. J Plast Reconstr Aesthet Surg 2010; 63: 360-364.
45. Ryssel H, Gazyakan E, Germann G, Ohlbauer M,. The use of Matriderm in early excision and simultaneous autologous skin grafting in burns: a pilot study. Burns 2008; 34: 93-97.
46. Schneider J, Biedermann T, Widmer D, Montano I, Meuli M, Reichmann E, et al. MatriDerm® versus Integra®: a comparative experimental study. Burns 2009; 35: 51-57.
47. Bloemen MCT, van Leeuwen MCE, van Vucht NE, van Zuijlen PP, Middelkoop E,. Dermal substitution in acute burns and reconstructive surgery: a 12-year follow-up. Plast Reconstr Surg 2010; 125: 1450-1459.
48. Rnjak J, Wise SG, Mithieux SM, Weiss AS,. Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng 2011; 17: 81-93.
49. Kolokythas P, Aust MC, Vogt PM, Paulsen F,. Dermal substitute with the collagen-elastin matrix Matriderm in burn injuries: a comprehensive review. Handchir Mikrochir Plast Chir 2008; 40: 367-371.
50. Gravante G, Delogu D, Giordan N, Morano G, Montone A, Esposito G,. The use of hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res 2007; 28: 269-274.
51. Myers SR, Partha VN, Soranzo C, Price RD, Navsaria HA,. Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy. Tissue Eng 2007; 13: 2733-2741.
52. Hansen SL, Voigt DW, Wiebelhaus P, Paul CN,. Using skin replacement products to treat burns and wounds. Adv Skin Wound Care 2001; 14: 37-44.
53. Cooper M, Hansbrough J, Spielvogel R, Cohen R, Bartel RL, Naughton G,. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12: 243-248.
54. Phillips TJ,. Biologic skin substitutes. J Dermatol Surg Oncol 1993; 19: 794-800.
55. Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD,. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft- Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997; 18: 43-51.
56. Purdue GF, Hunt JL, Still JM, Jr, Law EJ, Herndon DN, Goldfarb IW, et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997; 18: 52-57.
57. Purdue GF,. Dermagraft-TC pivotal safety and efficacy study. J Burn Care Rehabil 1997; 18: S13-14.
58. Hansbrough J,. Status of cultured skin replacement. Wounds 1995; 7: 130-136.
59. Bouchle A,. Tissue engineering firms go under. Nat Biotechnol 2002; 20: 1178-1179.
60. Truong AN, Kowal-Vern A, Latenser BA, Wiley DE, Walter RJ,. Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds 2005; 4: e4.